Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
44 studies found for:    Open Studies | "Carcinoma, Basal Cell"
Show Display Options
Rank Status Study
1 Unknown  Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma
Condition: Carcinoma, Basal Cell
Intervention: Drug: Imiquimod 5% cream
2 Not yet recruiting Erismodegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma
Conditions: Basal Cell Carcinoma of the Skin;   Nevoid Basal Cell Carcinoma Syndrome;   Recurrent Skin Cancer
Interventions: Drug: buparlisib;   Drug: erismodegib;   Other: laboratory biomarker analysis;   Other: questionnaire administration
3 Not yet recruiting Photodynamic Therapy Using Blue Light or Red Light in Treating Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome
Conditions: Basal Cell Carcinoma of the Skin;   Nevoid Basal Cell Carcinoma Syndrome
Interventions: Drug: aminolevulinic acid hydrochloride;   Drug: photodynamic therapy;   Other: laboratory biomarker analysis;   Other: questionnaire administration
4 Not yet recruiting One-stop-shop Study for Treatment of Basal Cell Carcinoma Using Reflectance Confocal Microscopy
Condition: Carcinoma, Basal Cell
Interventions: Device: Reflectance confocal microscopy;   Procedure: Punch biopsy;   Procedure: Surgical excision
5 Unknown  Mohs Versus Traditional Surgery - Basal-Cell Carcinomas (BCC)
Condition: Carcinoma, Basal Cell
Intervention:
6 Recruiting Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate
Condition: Superficial Basal Cell Carcinoma
Interventions: Drug: Methylaminolevulinate PDT in 2 sessions;   Drug: Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT
7 Recruiting New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)
Conditions: Skin Neoplasms;   Carcinoma, Basal Cell
Interventions: Drug: MAL-PDT re-treatment;   Drug: usual MAL-PDT
8 Unknown  Periocular Basal Cell Carcinoma (BCC): Permanent vs. Frozen Section Pathological Control
Condition: Basal Cell Carcinoma
Interventions: Procedure: Permanent Section Control;   Procedure: Frozen Section Control
9 Recruiting Topical Itraconazole in the Treatment of Basal Cell Carcinoma
Condition: Basal Cell Carcinoma
Intervention: Drug: Itraconazole
10 Unknown  Evaluating In Vivo OCT Imaging for Periocular Basal Cell Carcinoma
Condition: Basal Cell Carcinoma
Intervention: Other: OCT
11 Recruiting Intralesional Cryosurgery for Basal Cell Carcinoma - a Feasibility Study
Condition: Basal Cell Carcinoma (BCC)
Intervention: Procedure: Intralesional cryotherapy
12 Unknown  A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base
Condition: Basal Cell Carcinoma
Interventions: Drug: Imiquimod cream;   Procedure: curettage and cautery
13 Not yet recruiting Surgical Excision Versus Curettage Prior to Imiquimod for the Treatment of Nodular Basal Cell Carcinoma
Condition: Nodular Basal Cell Carcinoma
Interventions: Drug: Imiquimod 5% cream with prior curettage;   Procedure: Standard surgical excision
14 Recruiting Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma
Conditions: Locally Advanced Basal Cell Carcinoma;   Skin Cancer;   Cutaneous Malignancy
Interventions: Drug: Vismodegib;   Radiation: Radiation therapy
15 Unknown  Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight
Conditions: Photodynamic Therapy;   Basal Cell Carcinomas
Intervention: Procedure: Daylight mediated photodynamic therapy
16 Recruiting A Study of Vismodegib With Surgery in Patients With Previously Untreated Basal Cell Carcinoma
Condition: Basal Cell Carcinoma
Interventions: Drug: Placebo;   Drug: vismodegib
17 Recruiting An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)
Condition: Basal Cell Carcinoma
Intervention:
18 Recruiting STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
Condition: Basal Cell Carcinoma
Intervention: Drug: vismodegib
19 Not yet recruiting An Observational Study to Determine the Clinical Cure Rate of Therapeutic up Front Shave Removal of Basal Cell Carcinoma of the Skin With Long Term Follow up to Evaluate Recurrence
Condition: Basal Cell Carcinoma
Intervention: Procedure: Deep shave removal using a blue surgical blade
20 Recruiting Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy
Condition: Basal Cell Carcinoma (BCC)
Interventions: Drug: BF-200 ALA;   Drug: methyl-aminolevulinate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years